High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Medicine

Background:

• Systemic inflammation is increasingly recognized as a significant factor influencing disease severity and prognosis.
• The COVID-19 pandemic has underscored the need for reliable biomarkers to predict patient outcomes.
• Inflammatory markers play a crucial role in understanding the host's response to viral infections.

Purpose of the Study:

• To emphasize the clinical significance of the neutrophil to lymphocyte ratio (NLR) as a predictor of outcomes in COVID-19.
• To highlight the utility of NLR in managing patients during the COVID-19 pandemic.
• To discuss the role of NLR in assessing systemic inflammation in COVID-19.

Main Methods:

• This viewpoint synthesizes existing research and clinical observations.
• It focuses on the interpretation of laboratory parameters, specifically the NLR.
• The analysis is based on data from patients infected with SARS-CoV-2.

Main Results:

• Elevated NLR is associated with more severe COVID-19 disease.
• The NLR serves as a readily available and cost-effective indicator of systemic inflammation.
• Changes in NLR can reflect disease progression and patient response to treatment.

Conclusions:

• The neutrophil to lymphocyte ratio is a valuable prognostic biomarker for COVID-19.
• Monitoring NLR can aid clinicians in risk stratification and treatment decisions for COVID-19 patients.
• Further research into inflammatory markers like NLR is essential for improving COVID-19 management.